文献速递眼底病与葡萄膜炎青光眼神经眼科

Neuritin1顺式调控元件实现视网膜神经节细胞优先基因表达

Neuritin1 Cis-Regulatory Elements Enable Gene Expression Preferentially in Retinal Ganglion Cells.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

研究通过分析转录组数据发现Nrn1在视网膜神经节细胞(RGC)中高表达,构建人/鼠Nrn1启动子-增强子组合(PEC)装入AAV2载体,玻璃体腔注射C57BL6/J小鼠,在年轻、老年及视神经夹伤(ONC)视网膜中评估转导效率和RGC特异性。结果显示人Nrn1-PEC驱动基因在RGC表达,超过83%转导细胞为RBPMS+,且在老年和ONC后仍保持强选择性,为青光眼等视神经病变基因治疗提供平台。

要点

  • 人Nrn1-PEC在AAV2中驱动RGC优先表达,超83%转导细胞为RBPMS+。
  • Nrn1-PEC在老年小鼠和视神经夹伤后仍保持强且选择性转导。
  • 该PEC可用于评估神经保护干预并推动青光眼基因治疗转化。

核心结论

  • Nrn1-PEC可实现高效且耐损伤的RGC基因表达,解决细胞特异性靶向的关键限制。

研究设计与样本

  • 研究分析现有转录组数据鉴定Nrn1为视网膜中RGC高限制性表达基因。
  • 合成人/鼠Nrn1-PEC装入AAV2载体驱动核靶向报告基因GreenLantern。
  • AAV经玻璃体腔注射C57BL6/J小鼠,在年轻、老年及ONC视网膜中用免疫组化和RBPMS+细胞定量评估。

主要发现

  • AAV2携带人Nrn1-PEC驱动RGC基因表达,定量显示超过83%转导细胞为RBPMS+。
  • Nrn1-PEC的RGC选择性显著优于广泛表达启动子。
  • 在老年小鼠和ONC后,Nrn1-PEC仍保持强且选择性转基因表达。

关键数值与推荐

  • RGC选择性以转导细胞中RBPMS+比例评估,人Nrn1-PEC组超过83%。

临床怎么用

  • Nrn1-PEC可提高RGC特异性基因递送精度,适用于临床前神经保护研究。
  • 该平台有望加速青光眼及其他视神经病变基因治疗的转化开发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Retinal ganglion cells (RGCs) are essential for visual signal transmission, yet they are vulnerable to injury and degeneration. Gene modulation in RGCs using adeno-associated virus (AAV) offers a promising avenue for neuroprotection and regeneration, but promoters lack sufficient RGC specificity, limiting the precision needed for preclinical studies. This study aims to identify novel promoter-enhancer combinations (PECs) to achieve gene expression preferentially in RGCs. METHODS: We evaluated existing transcriptomic data to identify neuritin 1 (Nrn1) as a gene with highly restricted RGC expression in the retina. Synthetic PECs derived from human and mouse Nrn1 loci were incorporated into AAV2 vectors driving expression of a nuclear-targeted reporter GreenLantern. AAVs were delivered via intravitreal injection into C57BL6/J mice, and transduction efficiency and RGC specificity were evaluated in both young and aged retinas and those subjected to intraorbital optic nerve crush (ONC), using immunohistochemistry and quantitative analysis of RBPMS+ cells. RESULTS: We found that AAV2 with a human Nrn1-PEC drives gene expression in RGCs. Quantitative analysis revealed that over 83% of transduced cells were RBPMS+, indicating robust RGC selectivity and significantly outperforming ubiquitous promoters. Notably, the Nrn1-PEC retained strong and selective transgene expression in RGCs in aged mice and following ONC, demonstrating its resilience under aged and injury conditions. CONCLUSIONS: The Nrn1-PEC enables efficient and injury-resilient gene expression in RGCs, addressing a key limitation in cell-specific targeting. This AAV-incorporated PEC offers a robust platform for evaluating neuroprotective interventions and accelerates the translational development of gene therapies for glaucoma and other optic neuropathies.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Talla V, Koilkonda R, Kinane C, et al. Neuritin1 Cis-Regulatory Elements Enable Gene Expression Preferentially in Retinal Ganglion Cells. Invest Ophthalmol Vis Sci. 2026. PMID: 41954328. doi:10.1167/iovs.67.4.18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。